Dr. Lars Albermann, Merck KGaA - Qepler Summits And Conferences

Dr. Lars Albermann

Head of Pharma and Food Regulatory Subject Matter Experts
Merck KGaA
Frankfurt Am Main, Germany
We are Merck, a vibrant science and technology company. Science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. Through our three businesses we make a positive difference to millions of peoples’ lives every day. Our work is fueled by our belief in science as a force for good.

Originally a molecular biologist, Lars Albermann received his PhD from the Westfälische Wilhelms-Universität in Münster, Germany, in 2004. He subsequently spent 3 years as a postdoctoral researcher at the National University of Ireland, Galway.

He has been working in several regulatory positions in pharmaceutical industry as well as contributing to a number of industry associations over the last 12 years.

Currently, he is responsible for a team of regulatory experts at Merck Life Science Regulatory Management. The team is working on regulatory topics relevant for the entire portfolio of pharma and food related products on a global level.

Related Sessions:

Extractables & Leachables
Summit 2019

Get the latest updates in regulation, analytical testing, risk & safety assessment, biocompatibility.
  • 15 Oct 2019
  • Berlin, DE
  • Pharma
Day 1: Tuesday, 15 October 2019
CASE STUDY: USP <665> draft standard: A rational risk-based approach to characterization of polymeric biopharmaceutical manufacturing systems.

USP <665> draft will be the first standard for characterization of specifically single-use systems (SUS) used in manufacturing. In this session we will discuss:

  • Risk assessment with respect to patient safety to assign a risk level
  • Risk level appropriate testing of components
  • Approach for compliance for filters and SUS from a SUS supplier’s perspective
View Details